Bulk Pharmaceutical API Sources for glucagon hydrochloride

Bulk Pharmaceutical API Sources for glucagon hydrochloride

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		G2044_SIGMA
MolPort		MolPort-003-938-762
ISpharm		I06-1839
Chembase.cn		153945
Chembase.cn		154217
AvaChem Scientific		16941-32-5
AvaChem Scientific		2220

Glucagon Hydrochloride API Sourcing Landscape

Last updated: February 19, 2026

This report analyzes the bulk active pharmaceutical ingredient (API) sourcing landscape for glucagon hydrochloride, a critical therapeutic for hypoglycemia. It identifies key manufacturers, their production capabilities, regulatory compliance, and pricing dynamics.

What is the Global Market Size for Glucagon Hydrochloride API?

The global market for glucagon hydrochloride API is driven by the increasing prevalence of diabetes and related glycemic control needs. While specific market size figures for the API alone are often proprietary, the finished pharmaceutical product market offers an indication of demand. The global diabetes care market, which includes insulins and other glucose-lowering medications, was valued at approximately USD 80 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 6.5% through 2030 [1]. Glucagon hydrochloride holds a significant niche within this market for emergency glucose restoration.

Who are the Primary Manufacturers of Glucagon Hydrochloride API?

The manufacturing of glucagon hydrochloride API is concentrated among a limited number of specialized API producers, often with integrated capabilities from fermentation or synthesis to final purification. Key players include:

• Chr. Hansen A/S: A Danish company known for its fermentation expertise, Chr. Hansen is a significant supplier of biopharmaceuticals, including peptide-based APIs. Their production adheres to Good Manufacturing Practices (GMP) and is subject to stringent regulatory oversight.
• Lupin Limited: An Indian multinational pharmaceutical company, Lupin has a substantial API manufacturing division. They produce a range of complex APIs and possess robust quality control systems.
• Sun Pharmaceutical Industries Ltd.: Another major Indian pharmaceutical company, Sun Pharma is a diversified API producer with a global supply chain. Their facilities are regularly inspected by regulatory bodies.
• Eli Lilly and Company: While primarily known as a finished drug manufacturer, Lilly has historically produced its own glucagon API for its branded products. This internal capability signifies a high level of manufacturing expertise and quality assurance.
• Biocon Limited: An Indian biopharmaceutical company, Biocon specializes in biosimilars and complex biologics, which often involves peptide synthesis and fermentation. They operate under international GMP standards.

These manufacturers are characterized by their ability to handle complex peptide chemistry and ensure consistent product quality, a critical factor for parenteral administration.

What are the Regulatory Requirements for Glucagon Hydrochloride API Production?

Manufacturing of glucagon hydrochloride API is subject to rigorous regulatory oversight by health authorities worldwide. Key requirements include:

• Good Manufacturing Practices (GMP): Compliance with GMP guidelines, such as those set by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), is mandatory. This covers all aspects of production, from raw material sourcing to final product release, ensuring purity, potency, and consistency [2].
• Drug Master Files (DMFs) / Active Substance Master Files (ASMFs): API manufacturers must submit DMFs (in the US) or ASMFs (in Europe) to regulatory agencies. These confidential documents detail the manufacturing process, quality control measures, and stability data of the API, allowing drug product manufacturers to reference them in their marketing authorization applications [3].
• Impurity Profiling and Control: Strict limits are imposed on process-related impurities, degradation products, and residual solvents. Comprehensive analytical methods are required for their detection and quantification.
• Sterility and Endotoxin Testing: As glucagon hydrochloride is typically administered via injection, APIs must meet stringent requirements for sterility and low endotoxin levels, often demonstrated through pharmacopoeial monographs (e.g., USP, EP) [4].
• Traceability and Supply Chain Integrity: Manufacturers must maintain complete traceability of raw materials and intermediates. Robust supply chain management is essential to prevent counterfeiting and ensure product integrity.
• Environmental, Social, and Governance (ESG) Standards: Increasingly, regulatory bodies and pharmaceutical companies are scrutinizing the ESG practices of API manufacturers, including waste management, energy consumption, and labor practices.

What are the Production Methods for Glucagon Hydrochloride API?

Glucagon hydrochloride API is produced primarily through recombinant DNA technology and chemical synthesis.

• Recombinant DNA Technology: This method involves genetically engineering microorganisms, such as Escherichia coli or yeast, to produce glucagon. The process typically includes:

  • Gene insertion into a host organism.
  • Fermentation under controlled conditions to maximize protein expression.
  • Cell lysis and purification of the recombinant glucagon.
  • Conversion to the hydrochloride salt. This method is favored for its ability to produce highly pure and consistent peptide sequences. It requires specialized fermentation equipment and downstream processing capabilities.

• Chemical Synthesis: Solid-phase peptide synthesis (SPPS) or solution-phase synthesis can be employed to assemble the glucagon peptide chain amino acid by amino acid. This method involves:

  • Sequential coupling of protected amino acids onto a solid support or in solution.
  • Cleavage of the completed peptide from the support.
  • Deprotection of amino acid side chains.
  • Purification (often by High-Performance Liquid Chromatography - HPLC).
  • Conversion to the hydrochloride salt. Chemical synthesis offers precise control over peptide sequence but can be more complex and costly for longer peptides like glucagon, potentially leading to higher levels of related impurities if not meticulously controlled.

What are the Key Quality Control Parameters?

Quality control for glucagon hydrochloride API focuses on ensuring its safety, efficacy, and stability. Key parameters include:

• Purity: Determined by HPLC, this parameter ensures the absence of process-related impurities and degradation products. Specifications typically require purity exceeding 98%.
• Assay/Potency: Measures the biological activity or quantity of glucagon present. This is often determined by bioassays or validated HPLC methods and must fall within a defined range (e.g., 90-110% of the labeled amount).
• Related Substances: Quantifies specific known impurities and any unknown impurities. Limits are set based on toxicological data and regulatory guidelines.
• Endotoxins: Limits for bacterial endotoxins are critical for injectable products, typically measured in Endotoxin Units per milligram (EU/mg) and must be well below the threshold for parenteral administration.
• Sterility: For sterile-grade API, the absence of viable microorganisms is confirmed through microbiological testing.
• Water Content: Measured by Karl Fischer titration, to ensure stability and prevent degradation.
• pH: The pH of a reconstituted solution is important for solubility and patient comfort.
• Amino Acid Analysis: Confirms the correct amino acid composition and sequence of the peptide.
• Residual Solvents: Limits for solvents used during synthesis and purification are set according to ICH guidelines to ensure patient safety.

What is the Typical Pricing Structure and Factors Influencing Cost?

The pricing of glucagon hydrochloride API is influenced by several factors:

• Manufacturing Scale and Volume: Larger production runs generally lead to lower per-unit costs due to economies of scale.
• Production Method: Recombinant production can be cost-effective at scale but requires significant upfront investment in fermentation infrastructure. Chemical synthesis costs can be higher due to reagent expenses and purification complexity.
• Regulatory Compliance and Quality Standards: APIs manufactured under strict GMP conditions with comprehensive regulatory documentation (DMFs/ASMFs) command premium pricing.
• Raw Material Costs: The cost of amino acids, reagents, enzymes, and fermentation media can fluctuate and impact overall production costs.
• Yield and Process Efficiency: Higher process yields and efficient purification methods reduce waste and lower manufacturing expenses.
• Supply Chain Dynamics: Limited supplier options or geopolitical factors affecting raw material availability can lead to price volatility.
• Contractual Agreements: Long-term supply agreements can offer price stability and discounts for high-volume commitments.

Estimated Price Range (per kilogram): Based on industry estimates, bulk glucagon hydrochloride API can range from USD 5,000 to USD 25,000 per kilogram, depending heavily on the factors listed above, particularly supplier, quality, and volume. Small to medium volumes from specialized, GMP-compliant manufacturers will be at the higher end, while large, contracted volumes from established players may approach the lower end.

What are the Supply Chain Risks and Mitigation Strategies?

Key supply chain risks for glucagon hydrochloride API include:

• Single-Sourcing Dependence: Reliance on a sole manufacturer creates vulnerability to production disruptions, quality issues, or geopolitical events.
  • Mitigation: Identify and qualify at least two GMP-compliant suppliers. Diversify geographical sourcing where feasible.
• Raw Material Volatility: Fluctuations in the cost or availability of critical raw materials (e.g., amino acids, purification resins).
  • Mitigation: Establish long-term contracts with key raw material suppliers. Maintain safety stock of critical materials.
• Regulatory Hurdles: Delays in regulatory approvals for new API sources or changes in existing supplier facilities.
  • Mitigation: Proactively engage with regulatory agencies and ensure robust quality systems are in place. Maintain detailed documentation for all regulatory submissions.
• Geopolitical Instability: Events affecting manufacturing regions can disrupt production and logistics.
  • Mitigation: Monitor global geopolitical situations. Maintain flexibility in logistics and consider alternative shipping routes.
• Quality Deviations and Recalls: Unexpected quality issues can lead to production halts and product recalls, impacting supply.
  • Mitigation: Implement stringent supplier qualification programs, conduct regular audits, and establish robust incoming material testing protocols.

What are the Future Trends in Glucagon Hydrochloride API Sourcing?

Future trends in glucagon hydrochloride API sourcing are likely to include:

• Increased Focus on Biomanufacturing Efficiency: Advancements in fermentation technology and downstream processing are expected to improve yields and reduce costs for recombinant glucagon.
• Emergence of New Market Entrants: As demand grows, more API manufacturers, particularly in emerging markets with strong biopharmaceutical capabilities, may seek to enter the glucagon API space.
• Greater Emphasis on Supply Chain Transparency and Sustainability: Pharmaceutical companies will increasingly demand greater visibility into their API supply chains and favor manufacturers with strong ESG credentials.
• Technological Advancements in Peptide Synthesis: Innovations in chemical synthesis methodologies may lead to more efficient and cost-effective production of glucagon, potentially rivaling recombinant methods for certain scales.
• Consolidation and Strategic Partnerships: Expect continued consolidation among API manufacturers and potential for strategic partnerships between API producers and finished drug formulators to secure long-term supply.

Key Takeaways

• Glucagon hydrochloride API manufacturing is dominated by specialized producers with expertise in peptide synthesis and biomanufacturing, adhering to stringent GMP standards.
• Regulatory compliance, including DMF/ASMF submissions and adherence to USP/EP monographs, is paramount for API suppliers.
• Recombinant DNA technology and chemical synthesis are the primary production methods, each with distinct advantages and cost implications.
• API pricing is highly variable, influenced by production scale, regulatory status, manufacturing method, and supplier.
• Supply chain risks are significant, necessitating proactive mitigation strategies such as supplier diversification and robust quality management.
• Future trends point towards increased manufacturing efficiency, greater supply chain transparency, and potential market entry by new players.

Frequently Asked Questions

1. What is the typical lead time for securing a bulk order of glucagon hydrochloride API from a new supplier? Lead times for initial qualification and supply of bulk glucagon hydrochloride API from a new supplier typically range from 6 to 12 months. This timeframe includes supplier audits, sample testing, process validation, and regulatory documentation review.

2. Are there any specific pharmacopoeial monographs that glucagon hydrochloride API must comply with? Yes, glucagon hydrochloride API must comply with relevant pharmacopoeial monographs, primarily the United States Pharmacopeia (USP) and the European Pharmacopoeia (EP). These monographs define critical quality attributes, test methods, and acceptance criteria for purity, potency, impurities, and other parameters.

3. How does the cost of glucagon hydrochloride API compare to other peptide-based APIs? Glucagon hydrochloride API typically falls within a mid-to-high price range for peptide-based APIs. Its cost is generally higher than simpler synthetic peptides but may be lower than highly complex biologics or recombinant proteins requiring extensive post-translational modifications. Pricing is heavily dependent on the manufacturing scale and regulatory stringency.

4. What are the implications of different salt forms of glucagon for API sourcing? While glucagon hydrochloride is the most common form, other salt forms or even the free base might be produced for specific formulation needs or historical reasons. API buyers must ensure the sourced API matches their specific formulation requirements and regulatory filings for the intended salt form. Sourcing different salt forms may involve different manufacturers or specialized purification steps.

5. What is the shelf life typically guaranteed for glucagon hydrochloride API, and how is it determined? The shelf life of glucagon hydrochloride API is typically determined through comprehensive stability studies conducted according to International Council for Harmonisation (ICH) guidelines. These studies assess the API's degradation under various storage conditions (temperature, humidity, light). A typical guaranteed shelf life for a well-manufactured and properly stored glucagon hydrochloride API is between 24 to 36 months, but this can vary by manufacturer and specific formulation of the API.

Citations

[1] Grand View Research. (2023). Diabetes Care Market Size, Share & Trends Analysis Report By Therapy (Insulin, Oral Hypoglycemic Drugs, Other), By Product (Insulin Delivery Devices, Blood Glucose Monitoring Devices), By Region, And Segment Forecasts, 2023-2030.

[2] U.S. Food & Drug Administration. (n.d.). Current Good Manufacturing Practice (CGMP) Regulations. Retrieved from https://www.fda.gov/drugs/pharmaceutical-quality-resources/current-good-manufacturing-practice-cgmp-regulations

[3] European Medicines Agency. (n.d.). Active Substance Master File (ASMF). Retrieved from https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-active-substance-master-file-procedure-scientific-guideline_en.pdf

[4] United States Pharmacopeia. (n.d.). USP General Chapters. Retrieved from https://www.usp.org/compendial-customization/usp-general-chapters